In colorectal cancer, at least, the high frequency of APC and other mutations that stabilise β-catenin might, therefore, be expected to lead to induction of these Wnt antagonists, including the sFRPs, if they were not suppressed by other mechanisms before the onset of tumorigenesis. Here, APC is linked to colorectal cancer.